Bispecific antibodies improve outcomes in patients with relapsed or refractory multiple myeloma after CAR-T cell therapy Meeting Abstract
| Authors: | Merz, M.; Dima, D.; Hashmi, H.; Mueller, F.; Ahmed, N.; Rathje, K.; Davis, J.; Holderried, T.; Vucinik, V.; Kharbouti, S.; Ayuk, F.; Stoelzel, F.; Schub, N.; Schmitz, F.; Shune, L.; Khouri, J.; Anwer, F.; McGuirk, J.; Teichert, M.; von Tresckow, B.; Kroeger, N.; Pabst, T.; Abdallah, A. O.; Gagelmann, N. |
| Abstract Title: | Bispecific antibodies improve outcomes in patients with relapsed or refractory multiple myeloma after CAR-T cell therapy |
| Meeting Title: | 21st Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 24 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 25-28 |
| Meeting Location: | Rio de Janeiro, Brazil |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | S73 |
| End Page: | S74 |
| Language: | English |
| ACCESSION: | WOS:001325737900119 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(24)01959-1 |
| Notes: | Meeting Abstract: P-056 -- Source: Wos |
